Several previous studies reported that baseline CEA level was inversely correlated with pCR rate after CRT, but no report investigated whether CEA level could predict the response to ICIs.50,51 As the most frequently accepted CRC marker, we expect baseline CEA level as a reliable predictor for therapeutic effects of PD-1 blockade plus CRT. This evidence concerns the gene CEACAM5 and colorectal carcinoma.